Two National Surveys: Views of Americans and Health Care Providers on Medical Abortion
Will 1999 Be The Year For Mifepristone (RU-486)?
And, An Update on Women’s Other Options for Very Early Abortion
September 16, 1998
Briefing Participants:
Janet Benshoof
President
Center for Reproductive Law & Policy
120 Wall Street, 18th Floor
New York, NY 10005
Press Contact: Margie Kelly
212/514-5534
Jacqueline E. Darroch, PhD
Senior Vice President
The Alan Guttmacher Institute
120 Wall Street
New York, NY 10005
Vanessa Northington Gamble, MD, PhD
Associate Professor
History of Medicine and Family Medicine, and Director
Center for the Study of Race and Ethnicity in Medicine
University of Wisconsin-Madison Medical School
1300 University Avenue
Madison, WI 53706-1532
608/265-5996
Elizabeth Newhall, MD
Partner
Everywoman’s Health, P.C., and Medical Director
Downtown Women’s Center
401 North Graham, #445
Portland, OR 97227
503/284-5220
Felicia H. Stewart, MD
Director of Reproductive Health Programs
Kaiser Family Foundation
2400 Sand Hill Road
Menlo Park, CA 94025
Press Contact: Tina Hoff,
650/854-9400, ext. 210
Carolyn Westhoff, MD, MS
Associate Professor of Clinical Obstetrics and
Gynecology and Public Health
New York Presbyterian Hospital
Columbia Presbyterian Campus
Columbia University
630 West 168th Street, Room 16-80
New York, NY 10032
Press Contact: Karin Eskenazi
212/305-5587
Beverly Winikoff, MD
Senior Medical Associate
The Population Council
One Dag Hammarskjold Plaza
New York, NY 10017
Press Contact: Sandra Waldman
212/339-0525
Other Resources:
Mifepristone and Methotrexate Research
Mitchell D. Creinin, MD
Director of Family Planning & Family Planning Research
Department of OB/GYN & Reproductive Science
University of Pittsburgh School of Medicine
Magee-Women’s Hospital
300 Halket Street
Pittsburgh, PA 15213-3180
412/641-1440
David Grimes, MD
Vice President of Biomedical Affairs
Family Health International
PO Box 13950
Research Triangle Park, NC 27709-3950
919/544-7040
Richard Hausknecht, MD
Medical Director
Planned Parenthood of New York City
208 East 72nd Street
New York, NY 10021
212/369-1116
Mifepristone Clinical Trials
Lawrence Lader
President
Abortion Rights Mobilization
51 Fifth Avenue, 10th Floor
New York, NY 10003
212/255-0682
Eric Schaff, MD
Associate Professor
Department of Family Medicine
University of Rochester
885 South Avenue
Rochester, NY 14620
716/442-7470
Methotrexate Clinical Trials
Michael Burnhill, MD
Vice President of Medical Affairs
Planned Parenthood Federation of America
810 Seventh Avenue
New York, NY 10019-5818
Press Contact: Steve Plever
212/261-4310
Manual Vacuum Aspiration Research
Paul Blumenthal, MD
Associate Professor
JHU Department of OB/GYN
Johns Hopkins Bay View Medical Center
4940 Eastern Avenue
Baltimore, MD 21224
410/550-0335
Forrest C. Greenslade, PhD
President
IPAS
PO Box 100
Carrboro, NC 27510
919/967-7052
Patients’ Experiences With Medical Abortion
S. Marie Harvey, DrPH
Co-Director
Pacific Institute for Women’s Health
2999 Overland Avenue, Suite 111
Los Angeles, CA 90064
310/842-6828
Provider Training
Jodi Magee
Executive Director
Physicians for Reproductive Choice & Health
1780 Broadway, 10th Floor
New York, NY 10019
Press Contact: Ciara Wilson
212/765-2322
Vicki Saporta
Executive Director
National Abortion Federation
1755 Massachusetts, NW, Suite 600
Washington, DC 20036
Press Contact: Stephanie Mueller
202/667-5881
Policy And Politics
Elizabeth Cavendish
Legal Director
National Abortion & Reproductive Rights Action League (NARAL)
1156 15th Street, NW, Suite 700
Washington, DC 20005
202/973-3000
Marie Bass
Project Director
Reproductive Health Technologies Project
1818 N Street, NW, Suite 450
Washington, DC 20036
202/530-2900
Will 1999 Be The Year For Mifepristone (RU-486)?